GGrantIndex
← Leaderboards

Tuoqi Wu

University Of Colorado Denver

$3,991,747
Attributed
$3,991,747
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY201925
$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,991,747 · 4

By mechanism

R01$2,356,758 · 1
R21$902,000 · 2
R00$732,989 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Colorado Denver

Same institution · by research overlap

Research focus

Cd8-Positive T-LymphocytesImmunityAntiviral ImmunityTranscription FactorPathway InteractionsVirus DiseasesChronicT-LymphocyteCellsT-Lymphocyte SubsetsT Cell ResponseMouse ModelMediatingMalignant NeoplasmsCytokineReceptorResponseCd8b1 GeneProgramsExhibitsAffectMetabolicFlow CytometryHiv Infections

Grant awards (13)

Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection$555,764
R01 · FY2025 · AI · contact PI
Rescue T cell aging to improve CAR T cell production for elderly cancer patients$451,000
R21 · FY2025 · AG · contact PI
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection$544,369
R01 · FY2024 · AI · contact PI
Understand the molecular mechanism of age-associated decline in antiviral CD8 T cell immunity$246,000
R21 · FY2024 · AG · contact PI
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection$82,064
R01 · FY2024 · AI · contact PI
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection$540,929
R01 · FY2023 · AI · contact PI
Understand the molecular mechanism of age-associated decline in antiviral CD8 T cell immunity$205,000
R21 · FY2023 · AG · contact PI
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection$82,064
R01 · FY2023 · AI · contact PI
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection$551,568
R01 · FY2022 · AI · contact PI
Rejuvenating aged T cell immunity by targeting stem cell-like CD8 T cells$239,866
R00 · FY2021 · AG · contact PI
Rejuvenating aged T cell immunity by targeting stem cell-like CD8 T cells$1
R00 · FY2021 · AG · contact PI
Rejuvenating aged T cell immunity by targeting stem cell-like CD8 T cells$244,296
R00 · FY2020 · AG · contact PI
Rejuvenating aged T cell immunity by targeting stem cell-like CD8 T cells$248,826
R00 · FY2019 · AG · contact PI